Saptak Chem discloses no deviation in utilization of ₹1.05 crore raised via preferential convertible warrant issuance.
Funds were raised for working capital and bank guarantee margin as approved in November 2025 EGM.
The disclosure is a regulatory compliance filing under SEBI LODR Regulation 32(1) for Q4 FY26.
Audit Committee reviewed and confirmed no variation in fund usage from originally stated objects.